| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |